Skip to main content
OpenTrials

Clinical trial condition

Steroid-refractory Acute Graft-versus-host Disease

Explore clinical trials studying Steroid-refractory Acute Graft-versus-host Disease. Study availability and eligibility vary by location and protocol.

5 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Steroid-refractory Acute Graft-versus-host Disease trial results

Recruiting

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy

NCT04629833

Conditions
Steroid-refractory Acute Graft-versus-host Disease
Locations
  • Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud Amiens, France
  • CHU Jean Minjoz Besançon, France
  • Hopital Michallon Grenoble, France
  • CHRU Lille- Hopital Claude Huriez Lille, France
View all 42 locations
View Trial Details
Completed

Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

NCT03327857

Conditions
Steroid-refractory Acute Graft-versus-host Disease, Treatment-refractory Acute Graft-versus-Host Disease
Locations
  • City of Hope Duarte, California, United States
  • David Geffen School of Medicine at UCLA Los Angeles, California, United States
  • University of Miami - Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Emory University Atlanta, Georgia, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

Trial of Efficacy and Safety of MC0518 Versus Best Available Therapy in Participants With Steroid-Refractory Acute Graft Versus Host Disease

NCT06075706

Conditions
Steroid-refractory Acute Graft-versus-host Disease
Locations
  • CHU de Bordeaux - Hopital des Enfants Bordeaux, France
  • CHU Grenoble Alpes - Hopital Couple Enfant (HCE) La Tronche, France
  • Centre Hospitalier Universitaire de Lille CHU Lille - Hopital Jeanne de Flandre HJF Lille, France
  • Institut d'Hematologie et d'Oncologie Pediatrique (IHOPe) Lyon, France
View all 36 locations
View Trial Details

Related conditions